StockData
Emmaus Life Sciences, Inc. logo

Emmaus Life Sciences, Inc. (EMMA) stock

EMMAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.05−0.01 (-14.38%)

Close on Oct 19, 2026Market cap $6.03MP/E –Yield –

Emmaus Life Sciences total assets

Total assets on the balance sheet at the end of each period.

Emmaus Life Sciences's total assets was $16.37M at Jun 30, 2026. For fiscal 2025 it was $21.44M, down 9.2% from the year before. Over ten years it grew 32.0% a year on average. The highest annual figure on record is $59.54M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$21.44M-9.2%
FY2024Dec 31, 2024$23.60M-32.9%
FY2023Dec 31, 2023$35.18M-27.1%
FY2022Dec 31, 2022$48.23M-15.0%
FY2021Dec 31, 2021$56.73M-4.7%
FY2020Dec 31, 2020$59.54M+0.1%
FY2019Dec 31, 2019$59.46M+875.3%
FY2017Sep 30, 2017$6.10M+1090.4%
FY2016Sep 30, 2016$512.10K-9.7%
FY2015Sep 30, 2015$567.10K-57.6%
FY2014Sep 30, 2014$1.34M-4.7%
FY2013Sep 30, 2013$1.40M+1019.1%
FY2012Sep 30, 2012$125.30K-66.1%
FY2011Sep 30, 2011$370.00K+55.8%
FY2010Sep 30, 2010$237.50K–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$16.37M-29.9%
Q1 FY2026CQ1 2026Mar 31, 2026$18.70M-20.8%
Q4 FY2025CQ4 2025Dec 31, 2025$21.44M-21.6%
Q3 FY2025CQ3 2025Sep 30, 2025$20.76M-20.0%
Q2 FY2025CQ2 2025Jun 30, 2025$23.34M-21.0%
Q4 FY2024CQ4 2024Dec 31, 2024$23.60M-32.9%
Q3 FY2024CQ3 2024Sep 30, 2024$27.34M-42.4%
Q2 FY2024CQ2 2024Jun 30, 2024$25.94M-48.4%
Q1 FY2024CQ1 2024Mar 31, 2024$29.54M-39.6%
Q4 FY2023CQ4 2023Dec 31, 2023$35.18M-27.1%
Q3 FY2023CQ3 2023Sep 30, 2023$47.45M+12.4%
Q2 FY2023CQ2 2023Jun 30, 2023$50.29M+9.3%
Q1 FY2023CQ1 2023Mar 31, 2023$48.95M-4.9%
Q4 FY2022CQ4 2022Dec 31, 2022$48.23M-15.0%
Q3 FY2022CQ3 2022Sep 30, 2022$42.20M-29.7%
Q2 FY2022CQ2 2022Jun 30, 2022$45.99M-27.3%
Q1 FY2022CQ1 2022Mar 31, 2022$51.49M-17.2%
Q4 FY2021CQ4 2021Dec 31, 2021$56.73M-4.7%
Q3 FY2021CQ3 2021Sep 30, 2021$60.06M+0.2%
Q2 FY2021CQ2 2021Jun 30, 2021$63.28M+12.5%
Q1 FY2021CQ1 2021Mar 31, 2021$62.22M-5.7%
Q4 FY2020CQ4 2020Dec 31, 2020$59.54M+0.1%
Q3 FY2020CQ3 2020Sep 30, 2020$59.94M-4.6%
Q2 FY2020CQ2 2020Jun 30, 2020$56.25M-21.0%
Q1 FY2020CQ1 2020Mar 31, 2020$65.99M+982.5%
Q4 FY2019CQ4 2019Dec 31, 2019$59.46M+4797.5%
Q3 FY2019CQ3 2018Jun 30, 2019$62.83M+2485.4%
Q2 FY2019CQ2 2018Mar 31, 2019$71.22M+3883.7%
Q4 FY2017CQ3 2017Sep 30, 2017$6.10M+1090.4%
Q3 FY2017CQ2 2017Jun 30, 2017$1.21M+71.9%
Q2 FY2017CQ1 2017Mar 31, 2017$2.43M+268.3%
Q1 FY2017CQ4 2016Dec 31, 2016$1.79M+93.4%
Q4 FY2016CQ3 2016Sep 30, 2016$512.10K-9.7%
Q3 FY2016CQ2 2016Jun 30, 2016$706.40K+158.7%
Q2 FY2016CQ1 2016Mar 31, 2016$659.90K+45.4%
Q1 FY2016CQ4 2015Dec 31, 2015$924.30K+82.3%
Q4 FY2015CQ3 2015Sep 30, 2015$567.10K–
Q3 FY2015CQ2 2015Jun 30, 2015$273.10K–
Q2 FY2015CQ1 2015Mar 31, 2015$453.70K–
Q1 FY2015CQ4 2014Dec 31, 2014$507.10K–

More Emmaus Life Sciences figures

See a number that looks wrong?